Aarti Drugs Ltd (AARTIDRUGS) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 657348,
    "name": "Aarti Drugs",
    "stock_name": "Aarti Drugs",
    "full_name": "Aarti Drugs Ltd",
    "name_url": "stocks-analysis/aarti-drugs",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "416.35",
    "chg": 5.4,
    "chgp": "1.31%",
    "dir": 1,
    "prev_price": "410.95",
    "mcapval": "3,775.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 524348,
    "symbol": "AARTIDRUGS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE767A01016",
    "curr_date": "Aug 07, 03:30 PM",
    "curr_time": "20:50 PM",
    "last_traded_at": "Aug 07, 03:30 PM IST",
    "bse_nse_vol": "94.36 k",
    "exc_status": "Active",
    "traded_date": "Aug 07, 2026",
    "traded_date_str": "2026 08 07",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/aarti-drugs-657348-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Aarti Drugs Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aarti-drugs-ltd-is-rated-sell-by-marketsmojo-4141347",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AartiDrugsLtd_mojoScore_4141347.png",
        "date": "2026-08-07 10:12:01",
        "description": "Aarti Drugs Ltd is rated Sell by MarketsMOJO, with this rating last updated on 21 May 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 07 August 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Aarti Drugs Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-drugs-ltd-technical-momentum-shifts-amid-mixed-market-signals-4136987",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AartiDrugsLtd_technicaldot_4136987.png",
        "date": "2026-08-05 08:03:57",
        "description": "Aarti Drugs Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a modest day gain of 1.77%, the small-cap pharmaceutical company faces a challenging outlook as its MarketsMOJO grade was downgraded from Hold to Sell on 21 May 2026, underscoring caution among investors amid mixed technical indicators and underwhelming long-term returns compared to the broader Sensex."
      },
      {
        "title": "Aarti Drugs Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-drugs-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4134795",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AartiDrugsLtd_technicaldot_4134795.png",
        "date": "2026-08-04 08:06:03",
        "description": "Aarti Drugs Ltd has experienced a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bearish stance. Despite some bullish signals on weekly indicators, the overall technical landscape suggests caution for investors as the stock faces downward pressure amid a recent downgrade in its mojo grade to Sell."
      },
      {
        "title": "Aarti Drugs Q1 FY27: Modest Growth Masks Margin Resilience Amid Profitability Pressures",
        "link": "https://www.marketsmojo.com/news/result-analysis/aarti-drugs-q1-fy27-modest-growth-masks-margin-resilience-amid-profitability-pressures-4131719",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AartiDrugs_quaterlyResult_4131719.png",
        "date": "2026-08-01 13:17:59",
        "description": "Aarti Drugs Ltd., a prominent manufacturer of active pharmaceutical ingredients (APIs) and pharma intermediates, reported consolidated net profit of ₹50.17 crores for Q1 FY27 (June 2026 quarter), marking a decline of 9.10% quarter-on-quarter from ₹55.19 crores in Q4 FY26 and a 6.94% drop year-on-year from ₹53.91 crores in Q1 FY26. The ₹3,854-crore market capitalisation company faced headwinds from sequential profit compression despite maintaining operational margin discipline, with the stock trading at ₹423.50 as of July 31, 2026, reflecting a modest 2.64% gain on the day following the results."
      },
      {
        "title": "Aarti Drugs Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-drugs-ltd-technical-momentum-shifts-amid-mixed-market-signals-4127875",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AartiDrugsLtd_technicaldot_4127875.png",
        "date": "2026-07-30 08:01:37",
        "description": "Aarti Drugs Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of bullish and bearish signals across key indicators. Despite a modest day gain of 1.41%, the stock’s technical profile and recent rating downgrade to a Sell by MarketsMOJO highlight a cautious outlook for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Aarti Drugs Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-drugs-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4125081",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AartiDrugsLtd_technicaldot_4125081.png",
        "date": "2026-07-29 08:02:22",
        "description": "Aarti Drugs Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite some bullish weekly signals, monthly indicators suggest caution, reflecting a complex interplay of market forces and investor sentiment as the stock trades at ₹407.25, down 0.92% from the previous close."
      },
      {
        "title": "Aarti Drugs Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-drugs-ltd-technical-momentum-shifts-amid-mixed-market-signals-4123329",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AartiDrugsLtd_technicaldot_4123329.png",
        "date": "2026-07-28 08:03:15",
        "description": "Aarti Drugs Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of bullish and bearish signals across key technical indicators. Despite a modest day gain of 1.58%, the stock’s broader technical picture remains mixed, with divergent signals from MACD, RSI, moving averages, and other momentum oscillators, underscoring the need for cautious investor appraisal."
      },
      {
        "title": "Aarti Drugs Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aarti-drugs-ltd-is-rated-sell-4122360",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AartiDrugsLtd_mojoScore_4122360.png",
        "date": "2026-07-27 10:10:55",
        "description": "Aarti Drugs Ltd is rated Sell by MarketsMOJO, with this rating last updated on 21 May 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 27 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Aarti Drugs Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-drugs-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4116998",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AartiDrugsLtd_technicaldot_4116998.png",
        "date": "2026-07-23 08:02:39",
        "description": "Aarti Drugs Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, with recent indicators signalling a transition from sideways to mildly bearish trends. Despite some bullish weekly signals, the overall technical landscape suggests caution for investors as the stock faces downward pressure amid broader market challenges."
      }
    ],
    "total": 705,
    "sid": "657348",
    "stock_news_url": "https://www.marketsmojo.com/news/aarti-drugs-657348"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "04-Aug-2026",
      "details": "Intimation of Analyst /Institutional Investors Meeting",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "03-Aug-2026",
      "details": "Newspaper Publication on Financial results",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "03-Aug-2026",
      "details": "Q1FY27 Earning Conference call recording",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Aarti Drugs Ltd has declared <strong>20%</strong> dividend, ex-date: 09 Feb 26",
          "dt": "2026-02-09",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Aarti Drugs Ltd has announced <strong>3:1</strong> bonus issue, ex-date: 30 Sep 20",
          "dt": "2020-09-30",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Aarti Drugs Ltd is Rated Sell by MarketsMOJO

2026-08-07 10:12:01

Aarti Drugs Ltd is rated Sell by MarketsMOJO, with this rating last updated on 21 May 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 07 August 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Aarti Drugs Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-08-05 08:03:57

Aarti Drugs Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a modest day gain of 1.77%, the small-cap pharmaceutical company faces a challenging outlook as its MarketsMOJO grade was downgraded from Hold to Sell on 21 May 2026, underscoring caution among investors amid mixed technical indicators and underwhelming long-term returns compared to the broader Sensex.

Read full news article

Aarti Drugs Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-08-04 08:06:03

Aarti Drugs Ltd has experienced a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bearish stance. Despite some bullish signals on weekly indicators, the overall technical landscape suggests caution for investors as the stock faces downward pressure amid a recent downgrade in its mojo grade to Sell.

Read full news article

Aarti Drugs Q1 FY27: Modest Growth Masks Margin Resilience Amid Profitability Pressures

2026-08-01 13:17:59

Aarti Drugs Ltd., a prominent manufacturer of active pharmaceutical ingredients (APIs) and pharma intermediates, reported consolidated net profit of ₹50.17 crores for Q1 FY27 (June 2026 quarter), marking a decline of 9.10% quarter-on-quarter from ₹55.19 crores in Q4 FY26 and a 6.94% drop year-on-year from ₹53.91 crores in Q1 FY26. The ₹3,854-crore market capitalisation company faced headwinds from sequential profit compression despite maintaining operational margin discipline, with the stock trading at ₹423.50 as of July 31, 2026, reflecting a modest 2.64% gain on the day following the results.

Read full news article

Aarti Drugs Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-07-30 08:01:37

Aarti Drugs Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of bullish and bearish signals across key indicators. Despite a modest day gain of 1.41%, the stock’s technical profile and recent rating downgrade to a Sell by MarketsMOJO highlight a cautious outlook for investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

Aarti Drugs Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-07-29 08:02:22

Aarti Drugs Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite some bullish weekly signals, monthly indicators suggest caution, reflecting a complex interplay of market forces and investor sentiment as the stock trades at ₹407.25, down 0.92% from the previous close.

Read full news article

Aarti Drugs Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-07-28 08:03:15

Aarti Drugs Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of bullish and bearish signals across key technical indicators. Despite a modest day gain of 1.58%, the stock’s broader technical picture remains mixed, with divergent signals from MACD, RSI, moving averages, and other momentum oscillators, underscoring the need for cautious investor appraisal.

Read full news article

Aarti Drugs Ltd is Rated Sell

2026-07-27 10:10:55

Aarti Drugs Ltd is rated Sell by MarketsMOJO, with this rating last updated on 21 May 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 27 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Aarti Drugs Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-07-23 08:02:39

Aarti Drugs Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, with recent indicators signalling a transition from sideways to mildly bearish trends. Despite some bullish weekly signals, the overall technical landscape suggests caution for investors as the stock faces downward pressure amid broader market challenges.

Read full news article

View All News